Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient-Reported Outcomes Following Magnetic Resonance-Guided Radiation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis.
Westerhoff JM, Lalmahomed TA, Meijers LTC, Henke L, Teunissen FR, Bruynzeel AME, Alongi F, Hall WA, Kishan AU, Intven MPW, Verkooijen HM, van der Voort van Zyp JRN, Daamen LA. Westerhoff JM, et al. Among authors: teunissen fr. Int J Radiat Oncol Biol Phys. 2024 Sep 1;120(1):38-48. doi: 10.1016/j.ijrobp.2024.05.028. Epub 2024 Jun 4. Int J Radiat Oncol Biol Phys. 2024. PMID: 38838994 Free article. Review.
Daily online contouring and re-planning versus translation-only correction in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer.
Teunissen FR, van der Voort van Zyp JRN, de Groot-van Breugel EN, Verkooijen HM, Wortel RC, de Boer JCJ. Teunissen FR, et al. Phys Imaging Radiat Oncol. 2022 Sep 13;24:43-46. doi: 10.1016/j.phro.2022.09.002. eCollection 2022 Oct. Phys Imaging Radiat Oncol. 2022. PMID: 36148156 Free PMC article.
Adaptive magnetic resonance-guided neurovascular-sparing radiotherapy for preservation of erectile function in prostate cancer patients.
Teunissen FR, Wortel RC, Hes J, Willigenburg T, de Groot-van Breugel EN, de Boer JCJ, van Melick HHE, Verkooijen HM, van der Voort van Zyp JRN. Teunissen FR, et al. Phys Imaging Radiat Oncol. 2021 Sep 21;20:5-10. doi: 10.1016/j.phro.2021.09.002. eCollection 2021 Oct. Phys Imaging Radiat Oncol. 2021. PMID: 34604553 Free PMC article.
Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer.
Teunissen FR, Wortel RC, Wessels FJ, Claes A, van de Pol SMG, Rasing MJA, Meijer RP, van Melick HHE, de Boer JCJ, Verkooijen HM, van der Voort van Zyp JRN. Teunissen FR, et al. Clin Transl Radiat Oncol. 2021 Nov 14;32:29-34. doi: 10.1016/j.ctro.2021.11.005. eCollection 2022 Jan. Clin Transl Radiat Oncol. 2021. PMID: 34825071 Free PMC article.
The first patient-reported outcomes from the Utrecht Prostate Cohort (UPC): the first platform facilitating 'trials within cohorts' (TwiCs) for the evaluation of interventions for prostate cancer.
Teunissen FR, Willigenburg T, Meijer RP, van Melick HHE, Verkooijen HM, van der Voort van Zyp JRN. Teunissen FR, et al. World J Urol. 2022 Sep;40(9):2205-2212. doi: 10.1007/s00345-022-04092-2. Epub 2022 Jul 21. World J Urol. 2022. PMID: 35861861 Free PMC article. Clinical Trial.
Magnetic Resonance-Guided Adaptive Radiation Therapy for Prostate Cancer: The First Results from the MOMENTUM study-An International Registry for the Evidence-Based Introduction of Magnetic Resonance-Guided Adaptive Radiation Therapy.
Teunissen FR, Willigenburg T, Tree AC, Hall WA, Choi SL, Choudhury A, Christodouleas JP, de Boer JCJ, de Groot-van Breugel EN, Kerkmeijer LGW, Pos FJ, Schytte T, Vesprini D, Verkooijen HM, van der Voort van Zyp JRN. Teunissen FR, et al. Pract Radiat Oncol. 2023 May-Jun;13(3):e261-e269. doi: 10.1016/j.prro.2022.09.007. Epub 2022 Nov 30. Pract Radiat Oncol. 2023. PMID: 36462619 Free article.
Accumulated bladder wall dose is correlated with patient-reported acute urinary toxicity in prostate cancer patients treated with stereotactic, daily adaptive MR-guided radiotherapy.
Willigenburg T, van der Velden JM, Zachiu C, Teunissen FR, Lagendijk JJW, Raaymakers BW, de Boer JCJ, van der Voort van Zyp JRN. Willigenburg T, et al. Among authors: teunissen fr. Radiother Oncol. 2022 Jun;171:182-188. doi: 10.1016/j.radonc.2022.04.022. Epub 2022 Apr 28. Radiother Oncol. 2022. PMID: 35489444 Free article.
15 results